Answers are grounded in this paper and cite their sources.
5-methyltetrahydrofolate (5-MTHF) is the bioactive folate form, but gastric instability limits its application. We previously developed pectin-chitosan double-layer nanoliposomes (P-CH-NL) for 5-MTHF delivery. This study investigated their gastrointestinal fate and interactions with human gut microbiota using simulated digestion and in vitro fermentation models. Following upper gastrointestinal transit, the P-CH-NL structure was degraded by colonic microbiota, releasing 5-MTHF, which was putatively converted into active tetrahydrofolate (THF) via metabolic demethylation. Concurrently, the core-shell architecture of the polysaccharide coatings enhanced total short-chain fatty acids (SCFA) production, specifically promoting acetate, propionate, and butyrate generation. Furthermore, 16S rRNA sequencing revealed P-CH-NL beneficially modulated the microbiota composition by enriching core polysaccharide degraders such as Bacteroides , which concurrently decreased the Firmicutes/Bacteroidota ratio, and suppressing opportunistic pathogens ( Fusobacterium , Escherichia-Shigella ). In conclusion, by structurally mitigating the inherent antimicrobial limitations of chitosan, P-CH-NL exhibits a dual function of partial colonic retention and a prebiotic-like effect (not a formal prebiotic by ISAPP criteria), providing an experimental basis for developing functional foods to improve folate bioavailability and modulate gut microecology.
No takes yet. Share an insight, caveat, or question.
Mo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: